QuickView for n 1, 3- benzodioxol- 5- ylmethyl)- 2, 6- dichlorobenzamide

1. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
2. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
3. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)

There were no matches for n 1, 3- benzodioxol- 5- ylmethyl)- 2, 6- dichlorobenzamide

There were no clinical trials for n 1, 3- benzodioxol- 5- ylmethyl)- 2, 6- dichlorobenzamide